Although PD-L1 is predominantly expressed on tumor cells, it may also be expressed on antigen-presenting cells; hence, the PD-1/PD-L1 T cell inhibitory mechanism operates throughout several stages of an immune response. Here, PDCD1 is linked to neoplasm.